Name | CK 5 |
---|---|
Synonyms | 58 kDa cytokeratin; CK 5; CK5; Cytokeratin 5; DDD; EBS 2; EBS2; K5… |
Name | SMA |
---|---|
CAS | sodium 2-chloroacetate |
PubMed | Abstract | RScore(About this table) | |
---|---|---|---|
18941404 | Westfall DE, Folpe AL, Paner GP, Oliva E, Goldstein L, Alsabeh R, Gown AM, Amin MB: Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol. 2009 Jan;33(1):99-105. The immunoreactivity was as follows: PMP-CK (OSCAR) 7/10 (70%), CK (AE1/AE3) 7/9 (78%), CK 34betaE12 0/10 (0%), CK 5/6 0/9 (0%), p63 0/9 (0%), SMA 10/10 (100%), ALK 2/10 (20%); sarcomatoid urothelial carcinoma-CK (OSCAR) 15/22 (68%), CK (AE1/AE3) 14/20 (70%), CK 34betaE12 5/20 (25%), CK5/6 6/22 (27%), p63 11/22 (50%), SMA 16/22 (73%), ALK 0/22 (0%); and smooth muscle tumors-CK (OSCAR) 7/13 (54%), CK (AE1/AE3) 7/12 (58%), CK 34betaE12 0/12 (0%), CK 5/6 0/12 (0%), p63 3/13 (23%), SMA 11/13 (85%), ALK 0/13 (0%). |
2(0,0,0,2) | Details |
19843143 | Delgallo WD, Rodrigues JR, Bueno SP, Viero RM, Soares CT: Cell blocks allow reliable evaluation of expression of basal (CK5/6) and luminal (CK8/18) cytokeratins and smooth muscle actin (SMA) in breast carcinoma. Cytopathology. 2009 Oct 15. |
5(0,0,0,5) | Details |
18807040 | Mainka P, Kahlert S, Kirchner T, Mayr D, Diebold J: [Basal and myoepithelial phenotype of metastatic mammary carcinomas. Pathologe. 2008 Nov;29 Suppl 2:363-9. METHODS: Paraffin-embedded material from 244 primary breast carcinomas of patients with subsequent metastatic disease was stained immunohistochemically for CK 5/6, CK14, smooth-muscle actin, p63, estrogen receptor and progesterone receptor. |
4(0,0,0,4) | Details |
19184024 | Bocker W, Hungermann D, Decker T: [Anatomy of the breast] . Pathologe. 2009 Feb;30(1):6-12. Immunofluorescence studies have shown that the breast epithelium contains cytokeratin (CK) 5/14-positive precursor cells which give rise to CK8/18-positive glandular or sm-actin-positive myoepithelial cells. |
2(0,0,0,2) | Details |
20091704 | Mohammadi A, Rosa M, Masood S: The use of fine-needle aspiration biopsy samples for the assessment of basal phenotype in triple negative breast cancer patients: A correlative study. Diagn Cytopathol. 2010 Jan 20. Tissue microarray blocks were prepared and stained with six biomarkers (CK5/6, p63, SMA, EGFR, C-Kit, and p53). |
2(0,0,0,2) | Details |
19659836 | Kuroishi S, Suda T, Fujisawa T, Ide K, Inui N, Nakamura Y, Nakamura H, Chida K: Epithelial-mesenchymal transition induced by transforming growth factor-beta1 in mouse tracheal epithelial cells. Respirology. 2009 Aug;14(6):828-37. Epub 2009 Jul 29. The basal cell markers, cytokeratin-5 and cytokeratin-17, were colocalized within the cells expressing alpha-SMA. |
1(0,0,0,1) | Details |
20223349 | Defaud-Henon F, Tunon-de-Lara C, Fournier M, Marty M, Velasco V, de Mascarel I, MacGrogan G: [Adenoid cystic carcinoma of the breast: clinical, histological and immunohistochemical characterization]. Ann Pathol. 2010 Feb;30(1):7-16. Epub 2010 Feb 18. An immunohistochemical study was performed with the following antibodies: ER, PR, HER-2-neu, Vimentin, EGFR, P63, SMA, CK5/6, CK8/18, CK14, cKIT, MIB1, CD44 and CD24. |
1(0,0,0,1) | Details |
18844031 | Yang WT, Yu L, Lu HF, Zhang TQ: [Clinicopathologic study of intracystic papillary carcinoma of the breast] . Zhonghua Bing Li Xue Za Zhi. 2008 Apr;37(4):234-7. Immunohistochemical study of SMA, MSA, ER, PR, p63, AE1/AE3, 34betaE12 and CK5/6 was performed using Envision method. |
1(0,0,0,1) | Details |
19614993 | Hafezi-Bakhtiari S, Al-Habeeb A, Ghazarian D: Benign mixed tumor of the skin, hypercellular variant: a case report. J Cutan Pathol. 2009 Jul 10. Immunohistochemical studies revealed positive immunoreactivity for EMA, CEA, CD117, HWMK, LWMK, CK7, Androgen receptor and S100 in the ductal (epithelial) cells and positive immunereactivity for calponin, SMA, CK 5/6 and p63 in the myoepithelial component. |
1(0,0,0,1) | Details |
18227731 | Vasei M, Moch H, Mousavi A, Kajbafzadeh AM, Sauter G: Immunohistochemical profiling of Wilms tumor: a tissue microarray study. Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):128-34. Only one case was positive for CK5/6, CK13, CK14, and CK20. |
1(0,0,0,1) | Details |
17650214 | Rizkalla H, Toner M: Necrotizing sialometaplasia versus invasive carcinoma of the head and neck: the use of myoepithelial markers and keratin subtypes as an adjunct to diagnosis. Histopathology. 2007 Aug;51(2):184-9. METHODS AND RESULTS: Thirteen cases with the histological changes of NSM, eight SCCs and eight MECs were examined with the following immunohistochemical markers: calponin, S100, smooth muscle actin (SMA), p63, CK7, CK5, CK6 and CAM5.2. |
1(0,0,0,1) | Details |
19855377 | Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH: Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol. 2010 Jan;23(1):123-33. Epub 2009 Oct 23. Using a set of 61 invasive breast cancers earlier profiled into molecular subtypes with expression arrays, we defined specificity and sensitivity values for different immunohistochemical panels of basal keratins (CK5/6, CK14, CK17, 34 beta E12), CD117, EGFR, p63 and SMA in defining basal-like breast cancer. |
1(0,0,0,1) | Details |
20032423 | Angiero F, Sozzi D, Seramondi R, Valente MG: Epithelial-myoepithelial carcinoma of the minor salivary glands: immunohistochemical and morphological features. Anticancer Res. 2009 Nov;29(11):4703-9. RESULTS: Immunohistochemical analysis showed the tumor cells to be weakly positive for S100, cytokeratin (CK) CK5/6, CK7, CKAE-1/AE-3 and strongly positive for epithelial membrane antigen (EMA) and p63; they were focally positive for calponin and acute lymphoblastic leukemia antigen (CD10). |
1(0,0,0,1) | Details |